Serum vascular endothelial growth factor per platelet count in patients with biliary atresia

`1. Otte JB, de Ville de Goyet J, Reding R, Hausleithner V, Sokal E, Chardot C, et al. Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: a review. Hepatology. 1994; 20: 41S-48S.10.1002/hep.1840200711Search in Google Scholar

2. Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: a disease or a phenotype? Hepatology. 2002; 35:1297-304.Search in Google Scholar

3. Chen L, Goryachev A, Sun J, Kim P, Zhang H, Phillips MJ, et al. Altered expression of genes involved in hepatic morphogenesis and fibrogenesis are identified by cDNA microarray analysis in biliary atresia. Hepatology. 2003; 38:567-76.10.1053/jhep.2003.50363Open DOISearch in Google Scholar

4. Chongsrisawat V, Chatchatee P, Samransamruajkit R, Vanapongtipagorn P, Chottivittayatarakorn P, Poovorawan Y. Plasma endothelin-1 levels in patients with biliary atresia: possible role in development of portal hypertension. Pediatr Surg Int. 2003; 19:478-81.10.1007/s00383-003-0963-zSearch in Google Scholar

5. Chongsrisawat V, Kongtawelert P, Tongsoongnoen W, Tangkijvanich P, Vejchapipat P, Poovorawan Y. Serum hyaluronan as a marker reflecting the severity of cirrhosis and portal hypertension in postoperative biliary atresia. Pediatr Surg Int. 2004; 20:773-7.10.1007/s00383-004-1141-7Open DOISearch in Google Scholar

6. Vejchapipat P, Theamboonlers A, Chaokhonchai R, Chongsrisawat V, Chittmittrapap S, Poovorawan Y. Serum hepatocyte growth factor and clinical outcome in biliary atresia. J Pediatr Surg. 2004; 39:1045-9.10.1016/j.jpedsurg.2004.03.052Search in Google Scholar

7. Honsawek S, Chongsrisawat V, Vejchapipat P, Thawornsuk N, Tangkijvanich P, Poovorawan Y. Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr Surg Int. 2005; 21:73-7.10.1007/s00383-004-1329-xOpen DOISearch in Google Scholar

8. Honsawek S, Chongsrisawat V, Vejchapipat P, Thawornsuk N, Poovorawan Y. Association of serum levels of tissue inhibitors of metalloproteinase-1 with clinical outcome in children with biliary atresia. Asian Pac J Allergy Immunol. 2006; 24:161-6.Search in Google Scholar

9. Friedman SL. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology. 2004; 40:1041-3.10.1002/hep.20476Open DOISearch in Google Scholar

10. Friedman SL, Maher JJ, Bissell DM. Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference. Hepatology. 2000; 32:1403-8.10.1053/jhep.2000.20243Search in Google Scholar

11. Garcia-Monzon C, Sanchez-Madrid F, Garcia-Buey L, Garcia-Arroyo A, Garcia-Sanchez A, Moreno-Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology. 1995; 108:231-41.10.1016/0016-5085(95)90029-2Search in Google Scholar

12. Medina J, Arroyo AG, Sanchez-Madrid F, Moreno- Otero R. Angiogenesis in chronic inflammatory liver disease. Hepatology. 2004; 39:1185-95.10.1002/hep.2019315122744Search in Google Scholar

13. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology. 1998; 27:1554-62.10.1002/hep.510270613Search in Google Scholar

14. Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, et al. Hypoxia-induced VEGF and collagen expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 2002; 35:1010-21.10.1053/jhep.2002.32524Open DOISearch in Google Scholar

15. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999; 103:1231-6.10.1172/JCI6889Search in Google Scholar

16. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1:27-31. 10.1038/nm0195-27Search in Google Scholar

17. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7.10.1126/science.275.5302.964Search in Google Scholar

18. Rosmorduc O, Wendum D, Corpechot C, Galy B, Sebbagh N, Raleigh J, et al. Hepatocellular hypoxiainduced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol. 1999; 155:1065-73.10.1016/S0002-9440(10)65209-1Search in Google Scholar

19. Dvorak HF, Brown IF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hypermeability, and angiogenesis. Am J Pathol. 1995; 146:1029-39.Search in Google Scholar

20. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000; 407:242-8.10.1038/3502521511001067Search in Google Scholar

21. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer. 1998; 77:956-64.10.1038/bjc.1998.15821501089528841Search in Google Scholar

22. Webb NJA, Bottomley MJ, Watson CJ, Brenchley PEC. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci. 1998; 94:395-404.10.1042/cs09403959640345Open DOISearch in Google Scholar

23. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging? Clin Cancer Res. 2000; 6:3147-52.Search in Google Scholar

24. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut. 2001; 49:565-76.10.1136/gut.49.4.565172848711559656Search in Google Scholar

25. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol. 2002; 160:641-54.10.1016/S0002-9440(10)64884-5Search in Google Scholar

26. Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y, et al. JTE-522, a cyclooxygenase- 2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology. 2003; 125:556-71.10.1016/S0016-5085(03)00904-1Search in Google Scholar

27. Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 2002; 35:1010-2.10.1053/jhep.2002.32524Search in Google Scholar

28. Ankoma-Sey V, Wang Y, Dai Z. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology. 2000; 31:141-8.10.1002/hep.510310122Search in Google Scholar

29. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999; 77:527-43.10.1007/s001099900019Search in Google Scholar

30. Mochida S, Ishikawa K, Toshima K, Inao M, Ikeda H, Matsui A, et al. The mechanisms of hepatic sinusoidal endothelial cell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells. J Gastroenterol Hepatol. 1998; 13 (Suppl):S1-S5.10.1111/jgh.1998.13.s1.1Search in Google Scholar

31. Ishikawa K, Mochida S, Mashiba S, Inao M, Matsui A, Ikeda H, et al. Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem Biophys Res Commun. 1999; 254:587-93.10.1006/bbrc.1998.9984Search in Google Scholar

32. Jones MK, Szabo IL, Kawanaka H, Husain SS, Tarnawski AS. von Hippel-Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J. 2002; 16: 264-6.10.1096/fj.01-0589fjeSearch in Google Scholar

33. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. Portal hypertension. J Hepatol. 2000; 32:141-56.10.1016/S0168-8278(00)80422-5Open DOISearch in Google Scholar

34. Bosch J, Pizcueta P, Feu F, Fernandez M, Garcia-Pagan JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am. 1992; 21:1-14.10.1016/S0889-8553(21)00175-8Search in Google Scholar

35. Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology. 2004; 126: 886-94.10.1053/j.gastro.2003.12.01214988842Search in Google Scholar

36. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodes J, Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol. 2005; 43:98-103.10.1016/j.jhep.2005.02.02215893841Open DOISearch in Google Scholar

37. Shi B, Wang X, Yang Z. Vascular endothelial growth factors and liver diseases. Hepatogastroenterology. 2001; 48:1145-8.Search in Google Scholar

38. Aw MM, Mitry RR, Hughes RD, Dhawan A. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2007; 44:224-7.10.1097/MPG.0b013e31802c686b17255836Search in Google Scholar

39. Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer. 1999; 80:892-7.10.1038/sj.bjc.6690437236230010360671Search in Google Scholar

40. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res. 2000; 6:3147-52.Search in Google Scholar

41. Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, et al. Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res. 1997; 3:2187-90.Search in Google Scholar

42. Harrison P, Wilbourn B, Debili N, Vainchenker W, Breton-Gorius J, Lawrie AS, et al. Uptake of plasma fibrinogen into α granules of human megakaryocytes and platelets. J Clin Invest. 1989; 84:1320-4. 10.1172/JCI1143003297932677051Open DOISearch in Google Scholar